(R)-ethyl 3-(cyclohexanecarboxamido)-1,4'-bipiperidine-1'-carboxylate | 1240514-92-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (R)-ethyl 3-(cyclohexanecarboxamido)-1,4'-bipiperidine-1'-carboxylate
• 英文别名: ethyl 4-[(3R)-3-(cyclohexanecarbonylamino)piperidin-1-yl]piperidine-1-carboxylate
• CAS: 1240514-92-4
• 化学式: C₂₀H₃₅N₃O₃
• 分子量: 365.516
• InChiKey: NWXCHPFLJBTGEW-QGZVFWFLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  61.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (R)-3-Boc-氨基哌啶 在 盐酸 、 三乙酰氧基硼氢化钠 、 N,N-二异丙基乙胺 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 水 、 1,2-二氯乙烷 为溶剂， 生成 (R)-ethyl 3-(cyclohexanecarboxamido)-1,4'-bipiperidine-1'-carboxylate
  参考文献：
  名称：

  Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071

  摘要：

  Herein we report the discovery and SAR of a novel series of M-1 agonists based on the MLPCN probe, ML071. From this, VU0364572 emerged as a potent, orally bioavailable and CNS penetrant M-1 agonist with high selectivity, clean ancillary pharmacology and enantiospecific activity. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.08.084

文献信息

• [EN] AMIDOBIPIPERIDINECARBOXYLATE M1 ALLOSTERIC AGONISTS, ANALOGS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME<br/>[FR] ANTAGONISTES ALLOSTÉRIQUES DE L'AMIDOBIPIPÉRIDINECARBOXYLATE M1, ANALOGUES ET DÉRIVÉS DE CEUX-CI, ET PROCÉDÉS POUR LEUR FABRICATION ET LEUR UTILISATION
  申请人：UNIV VANDERBILT

  公开号：WO2010096703A1

  公开（公告）日：2010-08-26

  In one aspect, the invention relates to compounds having a general structure: Formula (I) which are useful as allosteric agonists of the M1 muscarinic receptor; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurodegenerative diseases, including Alzheimer's Disease. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

  在一个方面，该发明涉及具有一般结构的化合物：公式（I），这些化合物可用作M1胆碱能受体的变构激动剂；制备这些化合物的合成方法；包含这些化合物的药物组合物；以及使用这些化合物的方法，例如，在治疗神经退行性疾病，包括阿尔茨海默病。本摘要旨在作为在特定领域进行搜索的扫描工具，并不打算限制本发明。
• AMIDOBIPIPERIDINECARBOXYLATE M1 ALLOSTERIC AGONISTS, ANALOGS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME
  申请人：Lindsley Craig W.

  公开号：US20120088791A1

  公开（公告）日：2012-04-12

  In one aspect, the invention relates to compounds having a general structure: Formula (I) which are useful as allosteric agonists of the M 1 muscarinic receptor, synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurodegenerative diseases, including Alzheimer's Disease. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

  在某个方面上，本发明涉及具有一般结构式：公式（I）的化合物，该化合物有助于作为M1肌动蛋白受体的别构激动剂，制备该化合物的合成方法，包括该化合物的制药组合物以及使用该化合物的方法，例如，用于治疗神经退行性疾病，包括阿尔茨海默病。本摘要旨在作为特定领域搜索的扫描工具，不旨在限制本发明。
• Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071
  作者：Evan P. Lebois、Gregory J. Digby、Douglas J. Sheffler、Bruce J. Melancon、James C. Tarr、Hyekyung P. Cho、Nicole R. Miller、Ryan Morrison、Thomas M. Bridges、Zixiu Xiang、J. Scott Daniels、Michael R. Wood、P. Jeffrey Conn、Craig W. Lindsley

  DOI：10.1016/j.bmcl.2011.08.084

  日期：2011.11

  Herein we report the discovery and SAR of a novel series of M-1 agonists based on the MLPCN probe, ML071. From this, VU0364572 emerged as a potent, orally bioavailable and CNS penetrant M-1 agonist with high selectivity, clean ancillary pharmacology and enantiospecific activity. (C) 2011 Elsevier Ltd. All rights reserved.